ACRUX
Acrux is a specialty pharmaceutical company, developing and commercialising a range of patented, patient-preferred healthcare products for global markets, using its innovative technology to administer drugs through the skin. Acrux's product pipeline includes treatments of hormonal deficiencies, pain, central nervous system disorders and a contraceptive. 20 human clinical trials have been completed with 8 different drugs and the lead product, Evamist(TM), is nearing the end of a phase 3 trial in the USA.
ACRUX
Social Links:
Industry:
Pharmaceutical
Founded:
1998-01-01
Address:
Melbourne, Victoria, Australia
Country:
Australia
Website Url:
http://www.acrux.com.au
Total Employee:
11+
Status:
Active
Contact:
+61 3 8379 0100
Technology used in webpage:
Google Maps Mobile Non Scaleable Content HSTS Google Analytics 4 US Privacy User Signal Mechanism Google Maps API Common Name Invalid IIS 10 HSTS IncludeSubdomains PreLoad Sectigo SSL
Similar Organizations
DelSiTech
A Turku, Finland-based drug delivery and drug development company,
Exo Therapeutics
Exo Therapeutics is a small molecule drug discovery and development company.
Current Employees Featured
Stock Details
Investors List
BioScience Managers Limited
BioScience Managers Limited investment in Post-IPO Equity - Acrux
Omega Funds
Omega Funds investment in Venture Round - Acrux
Official Site Inspections
http://www.acrux.com.au Semrush global rank: 7.24 M Semrush visits lastest month: 850
- Host name: yoshi.trueagency.com.au
- IP address: 101.0.77.58
- Location: Haymarket Australia
- Latitude: -33.8591
- Longitude: 151.2002
- Timezone: Australia/Sydney
- Postal: 2000
More informations about "Acrux"
Investor Centre - Acrux
Mar 5, 2024 Welcome to the Acrux Limited investor centre. This section is designed to give current and potential investors access to our important public information. Annual Report …See details»
Investor Centre - Acrux
Acrux is listed on the Australian Stock Exchange (ASX) ASX Code: ACR. ABN: 72 082 001 152. Registered Office and Principal Business Address: 103-113 Stanley Street, West Melbourne, …See details»
About Acrux - Acrux
Investor Centre - Acrux
Acrux’s corporate governance framework provides guidance to support effective decision making, business practice, company culture and for the company to fulfil its duty to shareholders. The …See details»
Board of Directors - Acrux
Acrux's Board is comprised of outstanding achievers in the pharmaceutical industry, finance and business sectors. Ross Dobinson, appointed March 1998 , BBus (Acc) Chairman, Independent Non-executive Director. Ross has been a …See details»
Acrux - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +61 3 8379 0100 Acrux is a specialty pharmaceutical company, developing and commercialising a range of patented, patient …See details»
Acrux Limited - AnnualReports.com
Acrux Limited, a drug delivery company, engages in developing and commercializing a range of patient-preferred pharmaceutical products for global markets, using its patented technology to administer drugs through the skin.See details»
Acrux - Overview, News & Similar companies | ZoomInfo.com
View Acrux (www.acrux.com.au) location in Victoria, Australia , revenue, industry and description. Find related and similar companies as well as employees by title and much more. ... Acrux Org …See details»
Acrux Limited (ASX: ACR) - Stock Analysis
Oct 16, 2024 Acrux Limited, together with its subsidiaries, engages in the development and commercialization of generic and topically applied pharmaceutical products in Australia, …See details»
Investor Centre - Acrux
Acrux Half-Year 2018 Financial Report Appendix 4D Opens in new window: 21/02/2018: Investor Centre; Investor Fact Sheet; Corporate Governance; Announcements & Reports; Share Price …See details»
Acrux Limited - Company Profile Report | IBISWorld
Jun 30, 2022 Acrux Limited is a locally-owned, publicly-listed company, engaged in the development of prescription pharmaceutical products, using dermal and transdermal drug …See details»
What We Do - Acrux
Acrux (ASX: ACR) is a specialty pharma company with a successful track record of developing and commercialising a pipeline of topically applied pharmaceutical products. Research & …See details»
Acrux Ltd, ACR:ASX profile - FT.com - Financial Times
1 day ago Year on year Acrux Ltd 's revenues fell -32.11% from 11.93m to 8.10m. This along with an increase in the cost of goods sold expense has contributed to a reduction in net …See details»
21. Acrux - AusBiotech Ltd
Acrux. In March 2010, Melbourne-based Acrux (ASX:ACR) secured what was then the biggest licensing arrangement ever entered into by an Australian biotech, worth more than US$550 …See details»
ACRUX INVESTOR PRESENTATION - Australian Securities Exchange
Acrux product history Past Acrux outcomes Estradiol spray Currently sold as Evamist® in the United States. Currently sold as Lenzetto® in over 30 countries with milestones and revenue …See details»
Management Team - Acrux
Felicia has over 25 years of experience in the pharmaceutical/biotech industry and she joined Acrux in 2001. Felicia has previously held positions at Faulding Pharmaceuticals, the …See details»
Acrux Company Profile - Office Locations, Competitors, Revenue
Oct 28, 2024 Acrux $5.09 m in annual revenue in FY 2024. See insights on Acrux including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Home | ACRUX Search
[email protected] (08) 6801 7311; Home; Candidate Services; Jobs; Hourly Rate Services; More. Industry Specialists; Contact Us; ... Prior to engaging ACRUX …See details»
Our Values - Acrux
Our Values . Round the clock. Persistence, focus and passion drive results. Commitment doesn’t have a timetable. Innovation. Bold initiatives and idea generation – inspirationSee details»